Quote
roman18
Love how you say there are examples but are not being reported by those pushing it....So where are the reports?
It's all out there. You can find more if you want to go look.
Quote
Small Chloroquine Study Halted Over Risk of Fatal Heart ComplicationsA research trial of coronavirus patients in Brazil ended after patients taking a higher dose of chloroquine...developed irregular heart rates.
[
www.nytimes.com]
.
Quote
Patients are connected to continuous heart monitors and also get serial electrocardiograms (electrical monitoring of the heart) to look for abnormal heart rhythms before they become life-threatening. Some people have had to be taken off chloroquine or hydroxychloroquine therapies because the healthcare team found that they were developing one of these dangerous heart rhythms. Additionally, a patient who is sedated and on a ventilator cannot be assessed for other serious side effects of the drugs, such as changes in vision and hearing, neuropsychiatric events, and intense nausea.
[
www.poison.org]
.
Quote
The study on chloroquine, conducted in Brazil, found one-quarter of the patients taking the anti-malaria medication developed potentially deadly changes in the electrical system regulatingtheir heartbeats. While a small and imperfect study, it highlights the compelling need for more rigorous data.
Doctors in the United States have seen such heart issues with chloroquine and a similar but less toxic drug, an anti-inflammatory called hydroxychloroquine. Some medical systems are no longer using either to treat COVID-19, even if they initially tried it. Others use them only with careful monitoring.
[
www.usatoday.com]
.
Quote
There are already other clinical studies that showed it is not effective against COVID-19 as well as several other viruses. And, more importantly, it can have dangerous side effects, as well as giving people false hope.
[
www.sciencealert.com]
.
Quote
Many scientists have criticized the French trial as riddled with enough methodological flaws to render its findings unreliable or misleading. Biostatisticians from the United Kingdom and Ireland cited a basic failure: Investigators didn’t randomize the groups—essential to ensuring dependable comparisons. They also noted that six of the treated patients were lost to the study, five of whom fared badly—one died, three entered intensive care, and one stopped treatment because of nausea. Yet they were dropped from the analysis, potentially skewing the outcome.
[
www.sciencemag.org]
.
